EXTON,
Pa., Feb. 20, 2024 /PRNewswire/ -- West
Pharmaceutical Services, Inc. (NYSE: WST), a global leader in
innovative solutions for injectable drug administration, announced
today that the Company's Board of Directors has approved a
second-quarter 2024 dividend of $0.20
per share. The dividend will be paid on May
1, 2024, to shareholders of record as of April 24, 2024.
About West
West Pharmaceutical Services, Inc. is a leading provider of
innovative, high-quality injectable solutions and services. As a
trusted partner to established and emerging drug developers, West
helps ensure the safe, effective containment and delivery of
life-saving and life-enhancing medicines for patients. With 10,000
team members across 50 sites worldwide, West helps support our
customers by delivering approximately 48 billion components and
devices each year.
Headquartered in Exton,
Pennsylvania, West in its fiscal year 2023 generated
$2.95 billion in net sales. West is
traded on the New York Stock Exchange (NYSE: WST) and is included
on the Standard & Poor's 500 index. For more information, visit
www.westpharma.com.
All trademarks and registered trademarks used in this release
are the property of West Pharmaceutical Services, Inc. or
its subsidiaries, in the United States and other
jurisdictions, unless otherwise noted.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/west-announces-second-quarter-2024-dividend-302065487.html
SOURCE West Pharmaceutical Services, Inc.
